[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:dysarthria":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":47,"states":48},"Dysarthria",6,4,[8,15,21,27,33,40],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06094205","Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)",[],"RECRUITING","2026-08-26T02:15:39.267524Z","2026-05-05T02:43:27.923100Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05724173","Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia",[],"2026-08-26T02:16:00.194860Z","2026-05-05T02:43:27.833776Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT06874322","Voiceitt for People With Impairments in Speech",[],"2026-08-26T02:16:17.877565Z","2026-05-05T02:43:26.740683Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT07357428","Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)",[],"2026-08-26T02:19:29.119921Z","2026-05-05T02:35:31.911538Z",{"nct_id":34,"title":35,"phases":36,"status":37,"updated_at":38,"content_modified":39},"NCT07719582","Effectivity of P1821, a Novel Tongue Strengthening and Endurance Enhancing Speech Flow Exercise",[],"NOT_YET_RECRUITING","2026-08-26T02:16:32.589113Z","2026-07-24T01:27:14.916425Z",{"nct_id":41,"title":42,"phases":43,"status":44,"updated_at":45,"content_modified":46},"NCT06593860","Dysarthria Management for Minor Groups",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:39:57.435220Z","2026-05-05T02:43:27.073018Z",[],[49],{"state":50,"count":51,"slug":52},"California",3,"california"]